Recent Updates
Recently added Catalysts
RLAY Positive Sentiment Score: 60/100

Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

Tuesday, January 3, 2023 1 min read
Key Takeaway: CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, is scheduled to present at the 4

Market Sentiment Analysis

POSITIVE FACTORS

  • Relay Therapeutics will present at a significant healthcare conference.
  • Participation in the event highlights the company's ongoing initiatives.
  • The conference will provide a platform for networking and visibility.

Full Press Release Details

CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 2:15 p.m. PT. The presentation will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the presentation.
About Relay Therapeutics

Frequently Asked Questions

What is Relay Therapeutics?

Relay Therapeutics is a biopharmaceutical company focused on developing therapies.

Who can be contacted for information about Relay Therapeutics?

Caroline Glen can be contacted at 617-370-8837 for inquiries.

Who is the media contact for Relay Therapeutics?

Dan Budwick is the media contact at 1AB, reachable at 973-271-6085.

Tags: RLAY Viatris Investor Conferences Healthcare Relay Therapeutics biopharma healthcare conference J.P. Morgan
Last updated: Jan 3, 2023